Concord Medical Services Holdings (FRA:C2C) EV-to-OCF: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C2C Concord Medical Services Holdings Ltd FRA:C2C
51 GF Score
Price €6.25
GF Value €9.41
! 6 Warning Signs
View Full Analysis

What is Concord Medical Services Holdings EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Concord Medical Services Holdings's Enterprise Value is €920.85 Mil. Concord Medical Services Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil. Therefore, Concord Medical Services Holdings's EV-to-OCF for today is .

The historical rank and industry rank for Concord Medical Services Holdings's EV-to-OCF or its related term are showing as below:

FRA:C2C' s EV-to-OCF Range Over the Past 10 Years
Min: -86.42   Med: -26.18   Max: 90.76
Current: -36.82

During the past 13 years, the highest EV-to-OCF of Concord Medical Services Holdings was 90.76. The lowest was -86.42. And the median was -26.18.

FRA:C2C's EV-to-OCF is ranked better than
93.26% of 682 companies
in the Healthcare Providers & Services industry
Industry Median: 8.775 vs FRA:C2C: -36.82

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-19), Concord Medical Services Holdings's stock price is €6.25. Concord Medical Services Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.580. Therefore, Concord Medical Services Holdings's PE Ratio (TTM) for today is At Loss.


Concord Medical Services Holdings  (FRA:C2C) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Concord Medical Services Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.25/-2.580
=At Loss

Concord Medical Services Holdings's share price for today is €6.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Services Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.580.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Concord Medical Services Holdings EV-to-OCF Related Terms


Concord Medical Services Holdings EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Concord Medical Services Holdings's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Services Holdings EV-to-OCF Chart

Concord Medical Services Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.16 -34.42 -26.94 -19.23 -36.71

Concord Medical Services Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.94 0.00 -19.23 0.00 -36.71

FRA:C2C vs GBCS, ADIA, EHSI: EV-to-OCF Comparison

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings EV-to-OCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's EV-to-OCF falls into.


FRA:C2C
51GF Score
Concord Medical Services Holdings Ltd FRA:C2C
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Services Holdings EV-to-OCF Calculation

Concord Medical Services Holdings's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=920.845/0
=

Concord Medical Services Holdings's current Enterprise Value is €920.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Concord Medical Services Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued. The current stock price of €6.25 is trading 33.6% below its estimated GF Value™ of €9.41.

Key valuation signals for FRA:C2C:

  • EV-to-OCF:
  • GF Value™: €9.41 vs. price of €6.25 (33.6% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Medical Services Holdings Business Description

Other Exchanges CCM:USA
Address Hanwei Plaza Building, No. 7 Guanghua Road, Room A1-A5, 26th Floor, East Area, Chaoyang District, Beijing, CHN, 100020
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
51GF Score

Get the complete analysis for FRA:C2C

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€9.41
GF Value